Ignite Creation Date:
2024-05-06 @ 2:36 PM
Last Modification Date:
2024-10-26 @ 1:33 PM
Study NCT ID:
NCT04360096
Status:
TERMINATED
Last Update Posted:
2023-02-03
First Post:
2020-04-21
Brief Title:
Inhaled ZYESAMI Aviptadil Acetate for the Treatment of Severe COVID-19
Sponsor:
APR Applied Pharma Research sa
Organization:
APR Applied Pharma Research sa
Organization Data
Organization:
APR Applied Pharma Research sa
Class:
OTHER
Study ID:
RLF-100_002
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
APR Applied Pharma Research sa
Lead Sponsor Class:
OTHER
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None